Cargando…
The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study
BACKGROUND: Multimorbidity and polypharmacy are common problems among the older population globally. They not only reduce the quality of life of older adults but also increase the prevalence of potentially inappropriate medication (PIM) use. This study aimed to examine the prevalence and the predict...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506761/ https://www.ncbi.nlm.nih.gov/pubmed/34734035 http://dx.doi.org/10.21037/atm-21-4238 |
_version_ | 1784581754631225344 |
---|---|
author | Tian, Fangyuan Liao, Shili Chen, Zhaoyan Xu, Ting |
author_facet | Tian, Fangyuan Liao, Shili Chen, Zhaoyan Xu, Ting |
author_sort | Tian, Fangyuan |
collection | PubMed |
description | BACKGROUND: Multimorbidity and polypharmacy are common problems among the older population globally. They not only reduce the quality of life of older adults but also increase the prevalence of potentially inappropriate medication (PIM) use. This study aimed to examine the prevalence and the predictors of PIMs in hospitalized geriatric patients with multimorbidity and polypharmacy in Chengdu based on the 2015 American Geriatric Society Beers Criteria (2015 AGS Beers Criteria) and 2019 American Geriatric Society Beers Criteria (2019 AGS Beers Criteria). METHODS: From 2016 to 2018, a cross-sectional study was conducted using electronic medical data from nine tertiary hospitals in Chengdu. The 2019 and 2015 AGS Beers Criteria were used to evaluate the PIM status of older inpatients (age ≥65 years), and logistic regression was used to identify the risk factors for PIM use. RESULTS: A total of 17,352 inpatients were included in the study between 2016 and 2018. The prevalence of PIM use based on the 2019 AGS Beers Criteria (72.54%) was slightly higher than that based on the 2015 AGS Beers Criteria (70.10%). Further, the prevalence of PIM use based on the 2019 AGS Beers Criteria showed an increasing trend, from 71.17% in 2016 to 73.39% in 2018. Logistic regression demonstrated that female, advanced age, and polypharmacy were positively associated with PIM use in older adults. The most frequently used PIMs in the inpatients were diuretics, benzodiazepines, non-steroidal anti-inflammatory drugs, antipsychotics, and selective serotonin reuptake inhibitors. CONCLUSIONS: There is a high prevalence of PIM use in older inpatients with multimorbidity and polypharmacy in Chengdu. The 2019 AGS Beers Criteria is more sensitive for evaluating older adults in Chengdu than the 2015 AGS Beers Criteria. Further, based on the 2019 AGS Beers Criteria, the prevalence of PIM use is increasing year by year. Research on interventions rationing PIM use in the geriatric population in Chengdu are necessary in the future. |
format | Online Article Text |
id | pubmed-8506761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-85067612021-11-02 The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study Tian, Fangyuan Liao, Shili Chen, Zhaoyan Xu, Ting Ann Transl Med Original Article BACKGROUND: Multimorbidity and polypharmacy are common problems among the older population globally. They not only reduce the quality of life of older adults but also increase the prevalence of potentially inappropriate medication (PIM) use. This study aimed to examine the prevalence and the predictors of PIMs in hospitalized geriatric patients with multimorbidity and polypharmacy in Chengdu based on the 2015 American Geriatric Society Beers Criteria (2015 AGS Beers Criteria) and 2019 American Geriatric Society Beers Criteria (2019 AGS Beers Criteria). METHODS: From 2016 to 2018, a cross-sectional study was conducted using electronic medical data from nine tertiary hospitals in Chengdu. The 2019 and 2015 AGS Beers Criteria were used to evaluate the PIM status of older inpatients (age ≥65 years), and logistic regression was used to identify the risk factors for PIM use. RESULTS: A total of 17,352 inpatients were included in the study between 2016 and 2018. The prevalence of PIM use based on the 2019 AGS Beers Criteria (72.54%) was slightly higher than that based on the 2015 AGS Beers Criteria (70.10%). Further, the prevalence of PIM use based on the 2019 AGS Beers Criteria showed an increasing trend, from 71.17% in 2016 to 73.39% in 2018. Logistic regression demonstrated that female, advanced age, and polypharmacy were positively associated with PIM use in older adults. The most frequently used PIMs in the inpatients were diuretics, benzodiazepines, non-steroidal anti-inflammatory drugs, antipsychotics, and selective serotonin reuptake inhibitors. CONCLUSIONS: There is a high prevalence of PIM use in older inpatients with multimorbidity and polypharmacy in Chengdu. The 2019 AGS Beers Criteria is more sensitive for evaluating older adults in Chengdu than the 2015 AGS Beers Criteria. Further, based on the 2019 AGS Beers Criteria, the prevalence of PIM use is increasing year by year. Research on interventions rationing PIM use in the geriatric population in Chengdu are necessary in the future. AME Publishing Company 2021-09 /pmc/articles/PMC8506761/ /pubmed/34734035 http://dx.doi.org/10.21037/atm-21-4238 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Tian, Fangyuan Liao, Shili Chen, Zhaoyan Xu, Ting The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study |
title | The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study |
title_full | The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study |
title_fullStr | The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study |
title_full_unstemmed | The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study |
title_short | The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study |
title_sort | prevalence and risk factors of potentially inappropriate medication use in older chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506761/ https://www.ncbi.nlm.nih.gov/pubmed/34734035 http://dx.doi.org/10.21037/atm-21-4238 |
work_keys_str_mv | AT tianfangyuan theprevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy AT liaoshili theprevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy AT chenzhaoyan theprevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy AT xuting theprevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy AT tianfangyuan prevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy AT liaoshili prevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy AT chenzhaoyan prevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy AT xuting prevalenceandriskfactorsofpotentiallyinappropriatemedicationuseinolderchineseinpatientswithmultimorbidityandpolypharmacyacrosssectionalstudy |